Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
10/2003
10/23/2003WO2003007954A3 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
10/23/2003WO2002046128A3 Quaternary amino acids on solid supports
10/23/2003US20030199698 Anticoagulants such as 2'-tert-butylaminosulfonylbiphenyl-4-yl-(3-(5-methyl-1,2,4-oxadiazol-3 -yl)benzyl)(2-cyanoethyl) carbamate, used for prophylaxis of cardiovascular disorders
10/23/2003US20030199560 Bisaryl compound and medicament for cancer treatment comprising the same
10/23/2003US20030199559 Process for making amlodipine maleate
10/23/2003US20030199552 Amide derivatives as NMDA receptor antagonists
10/23/2003US20030199550 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/23/2003US20030199549 Novel piperidine based MCH antagonists for treatment of obesity and CNS disorders
10/23/2003US20030199548 Administering quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives containing one of the ring selected from benzene, pyridine, thienyl, furanyl, imidazolyl and triazolyl for therapy in pain management
10/23/2003US20030199540 Fluoroalkyoxybenzylamino derivatives of nitrogen containing heterocycles
10/23/2003CA2482341A1 Novel methoxybenzamide compounds for use in mch receptor related disorders
10/23/2003CA2480832A1 Nitric oxide donors, compositions and methods of use
10/22/2003EP1354868A1 Perfluoronated cycle-containing tertiary amines used as a basis for gas-conveying emulsions and device for the production thereof
10/22/2003EP1354587A1 Medicinal compositions for oral use
10/22/2003EP1353906A1 Process for the preparation of (3-cyano-1h-indol-7-yl)(4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof
10/22/2003EP1353905A2 Piperidine/piperazine-type inhibitors of p38 kinase
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
10/22/2003EP1353888A1 A recovery method
10/22/2003EP1353750A1 Stable free nitroxyl radicals as oxidation catalysts and process for oxidation
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003EP0976702B1 Method for inhibiting polymerization of a vinyl compound
10/22/2003EP0927184B1 3-substituted pyrido 4',3':4,5]thieno 2,3-d]pyrimidine derivatives, their preparation and their use
10/22/2003EP0892802B1 Spiro(cyclopent(b)indole-piperidines) and n-phenyl-hydrazon intermediates for their preparation, both being acetylcholinesterase and mao inhibitors
10/22/2003CN1451065A Chlorohydrin and cationic compounds having high affinity for pulp paper
10/22/2003CN1450992A Piperazine derivatives used as CCR5 antagonists
10/22/2003CN1450898A Compounds for treating fibromyalgia and chronic fatigue syndrome
10/22/2003CN1450894A Phenylethylamines and condensed rings variants as prodrugs of catecholamines and their use
10/22/2003CN1125053C Method of preparing norbenzomorphane as an intermediate in the preparation of pharmaceutically useful benzomorphane derivatives in particular
10/22/2003CN1125046C Butadiene derivatives and process for preparing thereof
10/22/2003CN1125044C Novel prostaglandin synthase inhibitors
10/21/2003US6635764 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc.
10/21/2003US6635661 Heterocyclic analgesic compounds and methods of use thereof
10/21/2003US6635658 Amino-tetralin derivatives as muscarinic receptor antagonists
10/21/2003US6635643 For treating conditions which are related to impairment of gastric emptying
10/21/2003US6635630 Respiratory system disorders; antiinflammatory agents
10/21/2003US6635284 Delivery of multiple doses of medications
10/21/2003US6635270 NMDA receptor agonist pharmaceutical compositions
10/16/2003WO2003084943A2 Terphenyl derivatives, preparation thereof, compositions containing same
10/16/2003WO2003084941A2 Hydroxamic acid derivatives
10/16/2003WO2003084929A1 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa
10/16/2003WO2003084928A1 Alpha, omega-dicarboximide derivatives as useful uro-selective α1α adrenoceptor blockers
10/16/2003WO2003084927A1 Haloalkenes, process for production thereof, and pest controllers containing the same
10/16/2003WO2003084917A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003WO2003084916A2 Compounds that modulate ppar activity and methods for their preparation
10/16/2003WO2003084540A2 Compositions comprising mmp7 modulators for the treatment of chronic pain
10/16/2003WO2003084533A1 N-`4-(2-imino-pyrrolidin-1-yl)phenyl!-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases
10/16/2003WO2003037271A3 Compounds, pharmaceutical compositions and methods of use therefor
10/16/2003WO2003022218A3 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof
10/16/2003WO2003016274A3 2-substituted piperidines that are ligands for monoamine receptors and transporters
10/16/2003WO2002100849A3 Novel nitriles useful as reversible inhibitors of cysteine proteases
10/16/2003WO2002076939A3 Cysteine protease inhibitors
10/16/2003US20030195356 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines
10/16/2003US20030195229 Administering viricides such as N-nonenyl glucosamine, and optionally with mixtures of nucleosides, nucleotides, immunomodulators or immunostimulants for prophylaxis viral diseases
10/16/2003US20030195227 Retroviral protease inhibitors
10/16/2003US20030195223 Antithrombotic agents
10/16/2003US20030195191 N-sulfonyl hydroxamic acid derivatives as inhibitors of cd23
10/16/2003US20030195190 For therapy of allergic rhinitis, ulcer or anorexia, diabetes, Alzheimer's disease, narcolepsy or attention deficit disorder
10/16/2003US20030192132 (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/16/2003CA2481888A1 Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockers
10/16/2003CA2481879A1 Hydroxamic acid derivatives
10/16/2003CA2481392A1 Terphenyl derivatives, preparation thereof, compositions containing same
10/16/2003CA2481035A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003CA2481026A1 N-`4-(2-imino-pyrrolidin-1-yl)phenyl!-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases
10/16/2003CA2478340A1 Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa
10/15/2003EP1351959A1 Novel pleuromutilin derivatives
10/15/2003EP1351946A2 Materials and methods to potentiate cancer treatment
10/15/2003EP1351938A1 Phenyl derivatives
10/15/2003EP1351937A1 Aryl piperidine derivatives as inducers of ldl-receptor expression
10/15/2003EP1351936A1 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
10/15/2003EP1351935A1 Aryl piperidine derivatives as inducers of ldl-receptor expression
10/15/2003EP1351933A1 Il-8 receptor antagonists
10/15/2003EP1351928A2 Novel n(phenylsulphonyl)glycine derivatives and their therapeutic use
10/15/2003EP1351921A1 Novel 1,4-diamino-2-alkenyl-benzene derivatives and colorants containing said compounds
10/15/2003EP1135370B1 Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
10/15/2003CN1449493A Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
10/15/2003CN1449382A Polyarylcarboxamides useful as lipid lowering agents
10/15/2003CN1449373A Process for producing methacryloyl reaction product
10/15/2003CN1124270C Cyclopentene derivatives useful as antagonists of the motilin receptor
10/15/2003CN1124260C Para retinoic acid
10/15/2003CN1124258C Substituted dihydropyridine dicarboxylic ester
10/14/2003US6632963 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
10/14/2003US6632895 Functionalized alkoxyamine initiators
10/14/2003US6632827 Compositions of optically pure (+) norcisapride
10/14/2003CA2291994C Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
10/14/2003CA2122911C 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
10/09/2003WO2003082842A1 Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase
10/09/2003WO2003082828A1 Substituted tetrahydroisoquinolines as c5a receptor modulators
10/09/2003WO2003082820A1 (1-indanone)-(1,2,3,6-tetrahydropyridine) derivative
10/09/2003WO2003082819A1 N-phenyl-n-(4-piperidinyl)amide derivative
10/09/2003WO2003082818A1 Alkaloids compounds, analgesic pharmaceuticals and their preparation
10/09/2003WO2003082808A1 Benzamide derivatives
10/09/2003WO2003082268A2 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/09/2003WO2003082260A2 Tuberculosis treatment using pleuromutilin derivatives
10/09/2003WO2003082205A2 Compounds and methods
10/09/2003WO2003082190A2 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003WO2003045917A3 Ccr-3 receptor antagonists vii
10/09/2003WO2002009686A3 Cdc25 phosphatase inhibitors
10/09/2003US20030191319 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/09/2003US20030191317 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
10/09/2003US20030191316 A 2-fluorocycloalkyl-2-hydroxy-2-phenyl-ethanoyl)oxy amine salt derivatives; antagonist for treating diseases associated with muscarine M3 receptors, respiratory system disorders; side effect reduction, use as inhalants